TABLE 2.
Animal | Infection route | Tropism variant | Localization of variant in the indicated tissuea |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Primary tissue |
Secondary tissue |
|||||||||||
LNs |
Spl | GALT |
||||||||||
Thy | BM | Ax | Ili | Ing | Col | IEL | LPL | |||||
BR24b | i.v. | X4 | NA | NA | + | + | + | + | + | − | − | − |
CA28c | i.v. | X4 | − | NA | + | + | + | − | − | + | − | − |
DG08d | i.r. | X4 | − | − | + | + | + | + | + | − | − | − |
Dual | − | + | + | + | + | − | + | + | − | + | ||
DR16d | i.r. | Dual | + | + | + | + | + | + | + | + | + | + |
The presence (+) or absence (−) of the indicated variant was determined by envelope sequence analysis. NA, not available; Thy, thymus; BM, bone marrow; Ax, axillary; Ili, iliac; Ing, inguinal; Col, colonic; Mes, mesenteric; Spl, spleen; GALT, gut-associated lymphoid tissues.
Tasca et al. (63).
Ho et al. (29); also unpublished data.
This study.